Retraction
LRSAM1 E3 Ubiquitin Ligase Promotes Choriocarcinoma Progression and Metastasis via p53/p21 Signaling Impediment
Paper Information
Record ID:
58203
Author(s):
Journal:
Publication Date:
August 31, 2022
Retraction Date:
December 29, 2023
(1.9 year years ago)
Subjects:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Hindawi
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (3)
3
Total Citations0
Post-Retraction2
Pre-Retraction0
Same DayHeavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Research Progress of Immunotherapy for Trophoblastic Tumors in Pregnancy
萌倩 王
Advances in Clinical Medicine
Published: Jan 2023
362 days before retraction
Retracted: LRSAM1 E3 Ubiquitin Ligase Promotes Choriocarcinoma Progression and Metastasis via p53/p21 Signaling Impediment
BioMed Research International
BioMed Research International
Open Access
Published: Jan 2023
362 days before retraction
Quick Stats
Total Citations:
4
Years Since Retraction:
1.9 year
Open Access:
Yes
Last Checked:
Jul 24, 2025